OMI

OMI

USD

Owens & Minor Inc. Common Stock

$3.490+0.130 (3.869%)

실시간 가격

Healthcare
Medical Distribution
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$3.360

고가

$3.555

저가

$3.270

거래량

2.21M

기업 기본 정보

시가총액

269.9M

산업

Medical Distribution

국가

United States

거래 통계

평균 거래량

2.31M

거래소

NYQ

통화

USD

52주 범위

저가 $3.27현재가 $3.490고가 $15.54

AI 분석 리포트

마지막 업데이트: 2025년 11월 5일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

Owens & Minor (OMI): A Shocking Plunge and a Company's Gamble on a New Future

November 05, 2025, 09:16 AM EDT

The Big Pivot and the Analyst's Axe

The story for Owens & Minor has been dominated by two recent, earth-shaking events. First, on October 30th, the company announced a radical strategic shift. It plans to sell its Products & Healthcare Services segment, a move designed to transform OMI into a "pure-play home-based care business." This isn't just a minor tweak; it's a complete reinvention of the company's identity.

The market's reaction was swift and brutal. Just a few days later, on November 3rd, UBS delivered the second blow. The investment bank downgraded OMI stock from Buy to Neutral and slashed its price target from $7 all the way down to $4. This move suggests that, for now, Wall Street sees more risk than reward in OMI's bold new direction.

A Look at the Carnage: The Chart Tells a Brutal Story

The price chart for OMI is a picture of recent devastation. For most of October, the stock traded in a relatively stable range, hovering around the $5.00 mark. That stability evaporated overnight.

Following the strategic announcement, the stock collapsed. On October 31st, it plunged nearly 20% on staggering volume--almost 7 million shares traded hands, triple the average. This was not a quiet drift downward; it was a stampede for the exits. The UBS downgrade only added to the pain, pushing the stock to a new 52-week low of $3.27.

The stock is now scraping the bottom of its yearly range. This is a critical moment. The price action shows a clear, violent rejection of the company's new strategy by investors.

DateClose PriceKey Event
2025-10-30$4.96Day of strategic pivot announcement
2025-10-31$3.97-19.9% post-announcement sell-off
2025-11-03$3.45Further drop after UBS downgrade
2025-11-04$3.49Bounced slightly off 52-week low ($3.27)

Searching for a Floor: What the AI Sees in the Rubble

After such a dramatic fall, the question is whether the selling is over. The provided data offers a confusing mix of signals.

On one hand, the short-term AI forecast anticipates a small bounce over the next three days, with predicted gains between 0.5% and 2.4%. This suggests the stock might be oversold and due for a minor relief rally. The extremely low P/E ratio of 1.88 also screams "cheap" to value-focused investors.

However, other data points raise serious red flags. The company's Return on Equity is a deeply negative -196.4%, indicating profound unprofitability. Furthermore, there are severe contradictions within the automated analysis provided. While one AI prediction points to a short-term bounce, another projects a target price of $1.01--a catastrophic drop from current levels. The system's summary brief mentions a "bullish breakout," which is completely disconnected from the reality of the stock's recent breakdown. This internal confusion in the data underscores the extreme uncertainty surrounding OMI right now.

The Bottom Line

Owens & Minor is a company in crisis and transition. Management has made a high-stakes bet on a future in home-based care, and the market has responded by punishing its stock.

For investors, this presents a classic high-risk scenario. The stock is undeniably cheap on a price-to-earnings basis, but it could be a value trap. The terrible profitability (ROE) and the market's clear vote of no confidence cannot be ignored. The conflicting automated signals only add to the murky outlook.

This stock is suitable only for highly risk-tolerant, speculative investors who have researched the company's new strategy and believe in its long-term potential. For anyone considering a position, a cautious approach is essential. Watching to see if the stock can build a stable base above its 52-week low of $3.27 would be a prudent first step. Any entry would demand a disciplined stop-loss to protect against further declines, as the path forward for OMI is anything but certain.


Disclaimer: This report is for informational purposes only and does not constitute financial advice, an offer to sell, or a solicitation of an offer to buy any security. The author is not a registered financial advisor. All investment decisions should be made in consultation with a qualified professional. Investing in stocks involves risk, including the possible loss of principal.

관련 뉴스

Analyst Upgrades

UBS Downgrades Owens & Minor to Neutral, Lowers Price Target to $4

UBS analyst Kevin Caliendo downgrades Owens & Minor from Buy to Neutral and lowers the price target from $7 to $4.

더 보기
UBS Downgrades Owens & Minor to Neutral, Lowers Price Target to $4
BusinessWire

Owens & Minor Reports Third Quarter 2025 Financial Results

Signed Definitive Agreement for the Sale of Products & Healthcare Services Segment Transaction Positions the Company as a Pure-Play Home-Based Care Business Owens & Minor, Inc. (NYSE:OMI) today reported

더 보기
Owens & Minor Reports Third Quarter 2025 Financial Results

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 11월 5일 오전 06:21

약세중립강세

69.4% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
가치
트레이딩 가이드

진입점

$4.01

익절

$4.30

손절

$3.58

핵심 요소

DMI는 약세 추세(ADX:13.5, +DI:23.3, -DI:29.5)를 보여 주의를 요합니다.
현재 가격이 지지선($4.02)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(20,054)의 27.3배로 극도로 강력한 매수 압력을 나타냅니다.
MACD 0.0079이(가) 신호선 0.0051 위에 있어 강세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기